News

USA - FDA calls for public comment on Genetically Engineered Salmon

DA has issued for public comment a draft environmental assessment (EA) related to the agency’s review of an application concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. FDA’s preliminary finding is that an approval of this application, under the specific conditions proposed in the application, would not have a significant impact (FONSI) on the U.S. environment. AquAdvantage Salmon is a product of AquaBounty Technologies, of Maynard, Mass.

December 21, 2012

FDA has issued for public comment a draft environmental assessment (EA) related to the agency’s review of an application concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. FDA’s preliminary finding is that an approval of this application, under the specific conditions proposed in the application, would not have a significant impact (FONSI) on the U.S. environment. AquAdvantage Salmon is a product of AquaBounty Technologies (AquaBounty), of Maynard, Mass.

AquAdvantage Salmon Draft Environmental Assessment (PDF)

AquAdvantage Salmon Preliminary Finding of No Significant impact (PDF)